-transparent.png){kind=logo}
Progressive multifocal leukoencephalopathy (PML) has been a devastating disease for HIV-1-infected patients since the beginning of the AIDS pandemic. Currently, highly active antiretroviral therapy (HAART) seems to improve the outcome of PML in many patients. We describe two cases of PML whose course worsened in spite of HAART, but had a good response to cidofovir.
Related Publications
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
August 2000,
Rinsho shinkeigaku = Clinical neurology,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
November 2001,
Mayo Clinic proceedings,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
January 2004,
Journal of child neurology,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
May 1999,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
April 2001,
AIDS (London, England),
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
September 1998,
The New England journal of medicine,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
March 1998,
AIDS (London, England),
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
February 2000,
Journal of neurology,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
October 2007,
Rinsho shinkeigaku = Clinical neurology,
J Portilla, and
V Boix, and
F Román, and
S Reus, and
E Merino
May 2003,
Journal of neurology,
